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Abstract In order to define the enzymes responsible for the 
maturation of the precursors of brain-derived neurotrophic factor 
(proBDNF) and neurotrophin-3 (proNT3), we have analysed their 
biosynthesis and intracellular processing by the proprotein con- 
vertases furin, PC1, PC2, PACE4, PC5 and its isoform PC5/6-B. 
In these studies, we utilized a vaccinia virus expression system in 
either BSC40 or the furin activity-deficient LoVo cells. Results 
demonstrated that in both cells furin and, to a lesser extent, 
PACE4 and PC516-B effectively process proBDNF and proNT3. 
Furthermore, we have determined that human proNT3 is sulfated, 
suggesting that processing of proNT3 occurs following the arrival 
of the precursor to the Trans Golgi Network. 
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I. Introduction 
Neurotrophins are a family of chemically related proteins 
that promote the survival, growth and maintenance of neurons 
in the central and peripheral nervous ystems. Levi-Montalcini 
and coworkers discovered nerve growth factor (NGF), the first 
member of the family, over forty years ago (for review see [1]). 
Since the cDNA structure coding for the precursor of NGF 
(proNGF) was reported [2], four other members of the family 
have been identified and their cDNAs cloned: brain-derived 
neurotrophic factor (BDNF) [3], neurotrophin-3 (NT3) [4,5], 
neurotrophin-4/5 (NT-4/5) [6] and neurotrophin-6 (NT-6) [7]. 
Sequence data predict that all neurotrophins are generated 
from 31 35 kDa precursors that contain at their N-termini, 
hydrophobic signal peptides followed by proregions containing 
sequences of contiguous basic amino acids. Intracellular cleav- 
age of the proneurotrophins to produce active growth factors 
occurs following pairs of basic amino acids of the type I precur- 
sor motif [8] Arg-X-(Lys/Arg)-Argi, where X = Ser, Val or Arg 
for proNGF/proNT-4/5, proBDNF/proNT-6 and proNT3, re- 
spectively. 
Recently, a family of mammalian processing enzymes (called 
convertases) evolutionary related to the serine proteinases of 
the bacterial subtilisin and yeast kexin types were characterized 
and shown to be responsible for the intracellular processing of 
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many precursors at both single and pairs of basic residues (for 
recent reviews, see [8-10]). So far, seven members of this subtil- 
isin/kexin-like convertase family are known and are named 
furin, PC1 (also called PC3), PC2, PACE4, PC4, PC5 (also 
called PC6) and the very recently discovered PC7 [11]. Of the 
known convertases, only furin [10], PC5/6-B [12], a C-termi- 
nally extended isoform of PC5 [13] and possibly PC7 [11] con- 
tain a C-terminal transmembrane domain. Since all members 
of the convertase family can cleave precursors at the consensus 
type I cleavage site Arg-X-(Lys/Arg)-Argl [14], it became ap- 
parent hat aside from cleavage specificity the cognate conver- 
tase(s) must also be correctly colocalized and possibly coregu- 
lated with their substrate within either the Trans Golgi Net- 
work (TGN) or in secretory granules [9,15,16]. Accordingly, 
studies on the colocalization of the neurotrophin mRNAs with 
those of the convertases and their coregulation revealed that 
more than one convertase can colocalize with the neurotro- 
phins [17]. Indeed, biochemical analysis of the processing of 
proNGF by the five possible candidate convertases revealed 
that furin, PACE4 and PC5/6-B are the best proNGF process- 
ing enzymes in both constitutively secreting and regulated cells 
[18]. 
In this work, we analysed the processing of proNT-3 and 
proBDNF by the convertases furin, PC1, PC2, PACE4 and 
PC5 and its isoform PC5/6-B. The very recent discovery of PC7 
[11] precluded its analysis in this report. For this purpose, we 
coexpressed each candidate convertase with the precursor sub- 
strates in either the kidney epithelial cell line BSC40 or the furin 
activity-deficient colon carcinoma cell line LoVo [19]. Pulse 
and/or pulse-chase data elucidated the biosynthetic pathway of 
proNT3 and proBDNF and their processing into NT3 and 
BDNF. 
2. Materials and methods 
2.1. Vaccinia virus ( VV), VV infections and biosynthetic labelings 
Purified recombinant VVs using the full-length mouse (m) PC1, 
mPC2, mPC5, mPC5/6-B and human (h) furin and PACE4 have been 
previously described [20]. The VV:hBDNF [21] and VV:hNT3 [10] 
using the full-length coding regions were obtained essentially as de- 
scribed [18,20]. The full-length cDNAs of hBDNF and hNT3 were 
generously provided by Regeneron. Cellular expression, biosynthetic 
labeling with [35S](Met + Cys), endoglycosidase H and N-glycanase di- 
gestions were performed as described [18,20]. 
2.2. Western blot analysis 
Concentrated conditioned media from LoVo cells expressing BDNF 
and one of the convertases were applied to a 13 22% T, 2.7% C gradient 
SDS-PAGE, electrophoresed and transferred toTrans-Blot Supported 
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Nitrocellulose Membrane (Bio-Rad). Non-specific binding sites were 
blocked by using 5% bovine serum albumin in Tris-buffered saline 
containing 0.1% Tween-20 (TBS-T). Blots were probed with antibodies 
raised against aconserved synthetic hBDNF decapeptide (amino acids 
4049; a gift from Dr. Eric Shooter) overnight at 4°C. After four washes 
(10 rain each) in TBS-T, the primary antibody was visualised using 
horse radish peroxidase-coupled donkey antirabbit antibodies (Jackson 
ImmunoResearch Laboratories), followed by peroxidase-catalysed 
chemiluminescence (enhanced chemiluminescence; Amersham) accord- 
ing to the manufacturer's in tructions. 
3. Results 
3.1. Processing of proNT3 
The candidate processing enzymes of proNT3 [10] were 
analysed by their ability to process proNT3 following their 
coexpression i  BSC40 cells using the vaccinia virus expression 
system. Fortunately, our NGF antibody readily cross-reacts 
with NT3 [22] and immunoprecipitates both proNT3 and NT3. 
As shown in Fig. 1, pulse-labeling the constitutive BSC40 cells 
for 30 min with [35S](Met + Cys) followed by a chase of 120 min 
demonstrated the formation of two forms of proNT3 of appar- 
ent masses of 33.5 kDa (major form) and 35 kDa, both of which 
are secretable and convertase-sensitive. When proNT3 and 
furin were coexpressed, both proNT3 forms diminished in in- 
tensity with a parallel increase in the ratio of mature 14 kDa 
NT3 to proNT3. It is interesting to note that, similar 
to proNGF, the NT3 precursor contains a single Asn-glyco- 
sylation site in the prosegment, 8 amino acids N-terminal 
to its presumed processing site within the sequence 
AsnArgThrSerArgArgLysArglTyrAlaGlu. From the relative 
intensities of the secreted and the remaining precursor forms 
estimated by scanning the autoradiogram, wepropose that the 
decreasing order of proNT3 processing by the convertases i  
similar to that for proNGF [18], viz. furin being the best candi- 
date, followed by PACE4; PC5/6-B with PC1 and PC5 being 
also somewhat effective but PC2 is inactive. This is especially 
apparent from the remaining amount of proNT3 in the me- 
dium. Notice that the proNT3 levels are about the same in the 
PC2 and wild-type xperiments suggesting that PC2 does not 
cleave proNT3. In contrast, PC5 and PC1 partially cleave 
proNT3 as evidenced by the reduced amounts of proNT3 in the 
medium. In the cases of furin, PACE4 and PC5/6B, we could 
not detect proNT3 in the medium (Fig. 1). 
In order to further substantiate the precursor-product rela- 
tionship of proNT3/NT3, we pulsed BSC40 cells expressing 
either proNT3 alone or in combination with furin for 120 min 
(W 2°) with Na2[3sSO4] or for 15 rain (p~s) with [3sS](Met + Cys) 
and then chased for 30 (pIsC3°), 60 (pI5C6°) or 120 (P'5C'2°) min 
(Fig. 2). Analysis of the immunoprecipitated ra iolabeled pro- 
teins revealed the presence of a 33.5 kDa proNT3 form at each 
time point and the gradual appearance of a 35 kDa form of 
proNT3. Concomitant with the increase in the levels of the 
(33.5 + 35) kDa forms of proNT3, we observed an increase in 
the levels of a 14 kDa form of NT3 both in the cells and media. 
It appears that both the 33.5 and 35 kDa NT3 precursors are 
sulfated whereas mature NT3 (14 kDa) is not. We also detected 
a 23 kDa immunoreactive sulfated protein in medium and cell 
extract which might be an N-terminally truncated form of 
proNT3, possibly resulting from cleavage of human proNT3 at 
the predicted sequence ArgGlnGlnArg-ArgTyrAsnSer [10]. 
Analysis of the state of glycosylation of proNT3 (Fig. 3) 
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Fig. 1. Processing of proNT3 by the convertases. BSC40 cells were 
infected with either [VV:hNT3 + VV:WT], [VV:hNT3 + VV:mPC5/ 
6-B], [VV:hNT3 + VV:mPC5], [VV:hNT3 + VV: hPACE4], 
[VV:hNT3 + VV:hfurin], [VV:hNT3 + W:mPC2] or [VV:hNT3 + 
VV: mPCl]. Following overnight incubations the cells were pulse-la- 
beled with [35S](Met + Cys) for 30 min. followed by a chase of 2 h. The 
media nd cell extracts were then immunoprecipitated with a fl-NGF 
antibody which cross-reacts with NT3. Notice the presence of two 
forms of proNT3 (major 33.5 kDa and minor 35 kDa) both of which 
can be secreted and converted tothe mature NT3 (14 kDa). A control 
immunoprecipitation of the [VV:hNT3 + VV:WT] infection with a 
preimmune rabbit serum (WT/RI.) is also shown. 
revealed that following a pulse of 2 h, the (33.5 + 35) kDa 
intracellular forms are both N-glycanase-sensitive andthe 33.5 
kDa form is partially Endo H-sensitive whereas the mature 14 
kDa NT3 is not digested by these enzymes. In the media, only 
small amounts of precursor are detected; however, the secreted 
33.5 kDa mature form of proNT3 was found to be N-glycanase- 
sensitive but Endo H-resistant. This suggests that proNT3 is 
glycosylated atits predicted single Asn-glycosylation site pres- 
ent at a distance of 8 amino acids preceding the major process- 
ing site whereas, as expected, NT3 is not N-glycosylated [10]. 
3.2. Processing of proBDNF 
In order to further evaluate the candidate convertases of 
proneurotrophins, we analysed the capability of some of the 
convertases to process human proBDNF [21]. This neurotro- 
phin is well known to be expressed ina number of neuronal and 
non-neuronal tissues, including the hippocampus, Schwann 
cells and fibroblasts [4,23,24]. Similar to proNGF and proNT3 
the predicted protein structure of human proBDNF [21] sug- 
gests that it contains a single Asn-glycosylation site 8 amino 
acids N-terminal to its presumed major cleavage site in the 
sequence Asn MetSerMetArgValArgArglHisSer. 
One of the major hurdles with analysing the processing of 
proBDNF is its relatively poor cross-reactivity with NGF anti- 
bodies as compared to NT3 and to the lack of BDNF-specific 
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immunoprecipitating antibodies. Therefore, we opted for the 
analysis of proBDNF by western blots using a specific BDNF- 
peptide antibody. As shown in Fig. 4, analysis of the media of 
the furin activity-deficient LoVo cells expressing proBDNF 
alone or in combination with either furin, PACE4, PC1, PC2 
or PC5 demonstrated that furin can promote the conversion of 
proBDNF into BDNF (14.5 kDa). The other convertases which 
are effective include PACE4, PC1 and PC5. As with proNGF 
[18] and proNT3, PC2 does not process proBDNF. Using these 
methods, we did not detect any proBDNF secreted into the 
medium. 
4. Discussion 
Developmental growth of the nervous ystem, neuronal sur- 
vival and repair of damaged neurons requires the production 
and release of one or more neurotrophin [25]. Synergy between 
two or more neurotrophins may be required for some neurons 
as well [26]. The neurotrophin precursors are subject to 
posttranslational modifications, including signal peptidase 
cleavage, N-glycosylation, in some cases sulfation, and limited 
proteolysis at specific pairs of basic residues. The regulation of 
the synthesis and processing machinery of each neurotrophin 
would, therefore, have to be finely tuned in order to allow for 
their coordinate release and actions. 
The results presented in this work on proBDNF, proNT3 
and in a previous study on proNGF [18], demonstrated that 
among the known mammalian serine proteinases of the subtil- 
isin/kexin family furin, PACE4 and PC5/6-B represent the best 
convertases of the neurotrophins. Therefore, the sum of the 
I-- 
Z 
P.I. 
-z -z - p120 
•=• proNT3 35 kDa 
proNT3 33.5 kDa 
(-NT3 14 kDa 
Z m n, 
k- 
Z 
lf.proNT3 33.5 kDa 
(-NT3 14 kDa 
CELLS MEDIA 
ExpressUS3SS 
C M 
Na213SS04] 
BSC40 
Fig. 2. Pulse and pulse-chase analysis of the processing of proNT3 in 
BSC40 cells in the absence or presence of furin. BSC40 cells were 
infected with either [VV:hNT3 + VV:WT] or [VV:hNT3 + 
VV:hfurin]. Following overnight incubations the cells were pulse-la- 
beled with [35S](Met +Cys) for 15 min (pls) followed by a chase of 30 
(PI5C3°), 60 (p15c6°) or 120 (pI5c12°) min or with Na2135SO4] for 2 h. 
The media and cell extracts were then immunoprecipitated with a 
fl-NGF antibody. Notice that proNT3 and a processing intermediate 
(23 kDa) is sulfated but that NT3 (14 kDa) is not. A control im- 
munoprecipitation of the 15-min pulse with a preimmune rabbit serum 
(P.I.) shows the immunoprecipitation of four faintly labeled intracellu- 
lar non-specific proteins which are not secreted and which are also 
found in the immunoprecipitates using the fl-NGF antibody. 
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Fig. 3. EndoH and N-glycanase digestions ofproNT3 and NT3. BSC40 
cells were infected with [VV: hNT3] and following an overnight incuba- 
tion the cells were pulse-labeled with [35S](Met +Cys) for 2 h and the 
cell extracts were immunoprecipitated witha fl-NGF antibody. The cell 
and media immunoprecipitates were then divided into three equal frac- 
tions: a control sample, one which was digested with EndoH and an- 
other with N-glycanase prior to electrophoresis ona 15% T, 1.3% C slab 
SDS-PAGE gel. 
present knowledge suggest that more than one convertase can 
process the neurotrophins, but that furin is the most efficient 
in processing these precursors. Whether other convertases not 
yet defined could also participate in this process is not yet 
known, especially with the recent discovery of the novel conver- 
tase PC7 which is widely expressed, including in areas known 
to synthesize the neurotrophins [28]. 
It must be stressed that the work presented in this study and 
an earlier one [18] was performed under conditions where both 
the substrate and the convertase were expressed at high levels. 
In vivo, the enzyme to substrate ratios may differ widely from 
one type of cell to the other, which may influence the nature 
of the convertase responsible for the processing of each neuro- 
trophin precursor. 
Our pulse-chase analysis data (Figs. 3,4) demonstrated that 
proNT3 (but not mature NT3) is sulfated, suggesting that proc- 
essing of proNT3 occurs following the arrival of this precursor 
at the TGN. A similar conclusion was also reached for proNGF 
[18]. These results are in agreement with others which suggested 
that the convertases do not become fully active until they reach 
the late compartments of the Golgi apparatus [8-10,14,27]. 
In conclusion, the present data provided the first study on 
the processing of the neurotrophin precursors proBDNF and 
proNT3 and together with a previous analysis of proNGF 
processing [18], suggested a unifying hypothesis whereby all the 
three neurotrophins could be processed by the same conver- 
tase(s). However, since the tissue-distribution f the neurotro- 
phins varies, it will be important in the future to colocalize the 
cognate convertase(s) with each neurotrophin under basal and 
activated cell states (e.g. during epileptic seizures) in order to 
250 N.G. Seidah et al. IFEBS Letters 379 (1996) 247-250 
BDNF 
I ~ ~1 
108.0-- ~ 
80.5-- 
49.5 - -  
32 .5 - -  
27.5 - -  
18.5 - -  
Mr x 10 -3 
139.9  - 
86 .8  - 
47 .8  - 
33 .3  - 
28 .6  - 
20 .7  - 
BDNF 
I ~- I 
w _ 
o- ~ u_ 
Fig. 4. Processing of proBDNF by the convertases. In two separate 
experiments, LoVo cells were infected with either (A): [VV: 
hBDNF + VV : WT], [VV: hBDNF + VV: mPOMC], [VV: 
hBDNF + VV:mPC1], [VV: hBDNF + VV:mPC2] or [VV: 
hBDNF + VV:hfurin] or (B): [W:hBDNF + VV:WT], 
[VV: hBDNF + VV:mPC5], [VV: hBDNF + VV:hPACE4] or [VV: 
hBDNF + VV:hfurin]. Following overnight incubations the cells were 
pulse-labeled with [3sS](Met + Cys) for 2 h and the media were electro- 
phoresed on a 13-22% T, 2.7% C gradient SDS-PAGE and the gels were 
blotted onto a nitrocellulose filter. Immunoblots were then performed 
with a specific BDNF antibody. The arrow indicates the migration 
position of mature (14.5 kDa) BDNF. 
study their possible coregulation [17]. For example, in the den- 
tate gyrus of the hippocampus which expresses ignificant 
amounts of mRNAs coding for furin and PC1 [16] as well as 
PC7 [11] but not for PACE4 or PC5/6-B [28], the cognate 
processing enzymes may be reduced to the former two with the 
possible participation of PC1 in the processing of proBDNF 
(Fig. 4) [17]. Future studies of the regulatory mechanism(s) of
neurotrophin and convertase coexpression and cohabitation i
neuronal and non-neuronal cells should be quite rewarding. 
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